Journal list Promote Sponsor
verified SJR 0,166 · Q4 • database Scopus / SJR & Web of Science indexed
Turk Osteoporoz Dergisi
Turkey · Galenos Publishing House
workspace_premium Q4 — Endocrinology, Diabetes and Metabolism visibility_off Double blind peer review lock_open Open Access

Turk Osteoporoz Dergisi

Turk Osteoporoz Dergisi is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism with an H index of 7. It is an CC BY-NC-ND Journal with a Double blind peer review review system The scope of the journal is focused on postmenopausal osteoporosis, osteoporosis. It has an SJR impact factor of 0,166 and it has a best quartile of Q4. It is published in English, Turkish. It has an SJR impact factor of 0,166.

ISSN: 2146-3816
Publisher: Galenos Publishing House
Category: Endocrinology, Diabetes and Metabolism
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,166 Q4
H-index 7
Acceptance rate pie_chart
59%
Source Acceptance_Rate
Time to publication hourglass_top
12 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
NPD Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,166

H-index

7

Docs (year)

15

Docs 3y

127

Total refs

357

Cites 3y

34

Citable 3y

123

Cites/Doc 2y

0.21

Ref/Doc

23.8

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs